- Home
- CEPU vs VRDN Comparison
CEPU vs VRDN Comparison
Compare CEPU & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- VRDN
- Stock Information
- Founded
- CEPU 1989
- VRDN 2006
- Country
- CEPU Argentina
- VRDN United States
- Employees
- CEPU 1181
- VRDN N/A
- Industry
- CEPU Electric Utilities: Central
- VRDN Medical Specialities
- Sector
- CEPU Utilities
- VRDN Health Care
- Exchange
- CEPU Nasdaq
- VRDN Nasdaq
- Market Cap
- CEPU 1.6B
- VRDN 1.6B
- IPO Year
- CEPU 2018
- VRDN N/A
- Fundamental
- Price
- CEPU $11.35
- VRDN $13.13
- Analyst Decision
- CEPU Hold
- VRDN Buy
- Analyst Count
- CEPU 1
- VRDN 12
- Target Price
- CEPU $12.00
- VRDN $36.44
- AVG Volume (30 Days)
- CEPU 312.6K
- VRDN 1.2M
- Earning Date
- CEPU 05-09-2025
- VRDN 05-07-2025
- Dividend Yield
- CEPU 2.72%
- VRDN N/A
- EPS Growth
- CEPU N/A
- VRDN N/A
- EPS
- CEPU 0.03
- VRDN N/A
- Revenue
- CEPU $715,974,448.00
- VRDN $302,000.00
- Revenue This Year
- CEPU $29.08
- VRDN N/A
- Revenue Next Year
- CEPU N/A
- VRDN $20,553.29
- P/E Ratio
- CEPU $35.02
- VRDN N/A
- Revenue Growth
- CEPU 8.10
- VRDN N/A
- 52 Week Low
- CEPU $7.07
- VRDN $9.90
- 52 Week High
- CEPU $16.60
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- CEPU 50.56
- VRDN 46.75
- Support Level
- CEPU $10.97
- VRDN $9.90
- Resistance Level
- CEPU $12.22
- VRDN $14.22
- Average True Range (ATR)
- CEPU 0.82
- VRDN 1.17
- MACD
- CEPU 0.15
- VRDN 0.18
- Stochastic Oscillator
- CEPU 75.63
- VRDN 74.77
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a private-sector power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.